tisotumab vedotin   Click here for help

GtoPdb Ligand ID: 11719

Synonyms: HuMax-TF-ADC | TF-011-MMAE | tisotumab vedotin-tftv | Tivdak®
Approved drug
tisotumab vedotin is an approved drug (FDA (2021))
Compound class: Antibody
Comment: Tisotumab vedotin is an antibody-drug conjugate (ADC) of an anti-factor 3 monoclonal antibody that is conjugated to the antineoplastic agent monomethyl auristatin E (MMAE; PubChem CID 11542188) [1]. Tisotumab vedotin causes adverse events that are associated with disrupted coagulation [4].
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2021))
International Nonproprietary Names Click here for help
INN number INN
10148 tisotumab vedotin
Synonyms Click here for help
HuMax-TF-ADC | TF-011-MMAE | tisotumab vedotin-tftv | Tivdak®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 571
Other databases
GtoPdb PubChem SID 458923754
Search PubMed clinical trials tisotumab vedotin
Search PubMed titles tisotumab vedotin
Search PubMed titles/abstracts tisotumab vedotin